Ainos Plans To Conduct the Study at National Taiwan University Hospital, a Premier Taiwanese Medical Center for HIV Management
The U.S. FDA Have Granted Orphan Drug Designation (ODD) for the Company's VELDONA® Low-Dose Oral Interferon Formulation as a Potential Treatment for Oral Warts in HIV-Positive Patients
Read MoreWritten by Sensori.Ai CEO Dr. A.K. Pradeep, "Neuro AI: How to Win the Minds of Consumers Using Neuroscience-Powered Gen AI" leverages his success working with the biggest global brands to capture the nonconscious mind of the consumer, where 95% of purchase decisions are made
Read More